Ceribell (CBLL) EBITDA Margin (2023 - 2026)

Ceribell (CBLL) posted EBITDA Margin of 78.3% for Q1 2026, down 32.95% on a QoQ basis from 58.89% in Q4 2025, and down 897.0% year-over-year from 9.82% in Q1 2025.

Ceribell (CBLL) EBITDA Margin (2023 - 2026) Analysis & Trends

Ceribell's EBITDA Margin history runs 4 years deep, the most recent figure standing at 78.3% for Q1 2026.

  • Quarterly EBITDA Margin fell 897.0% year-over-year to 78.3% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 68.31% (down 476.0% YoY) and the FY2025 annual result came in at 65.57%, down 490.0% from the prior year.
  • EBITDA Margin was 78.3% for Q1 2026 at Ceribell, down from 58.89% in the prior quarter.
  • Across five years, EBITDA Margin topped out at 55.08% in Q2 2024 and bottomed at 78.3% in Q1 2026.
  • A 4-year average of 64.41% and a median of 63.83% in 2023 frame the typical range for EBITDA Margin.
  • Peak annual rise in EBITDA Margin reached 1062 bps in 2025, while the deepest fall reached 1545 bps in 2025.
  • Ceribell's EBITDA Margin stood at 63.83% in 2023, then declined by 9 bps to 69.52% in 2024, then advanced by 15 bps to 58.89% in 2025, then plunged by 33 bps to 78.3% in 2026.
  • Business Quant data shows CBLL's EBITDA Margin at 78.3% in Q1 2026, 58.89% in Q4 2025, and 64.84% in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBITDA Margin (Qtr)
1 Abbott Laboratories 182.32 Bn 175.02 Bn 6.27 Bn 12.05%
2 Stryker 128.75 Bn 125.88 Bn 3.81 Bn 15.55%
3 Medtronic 107.83 Bn 98.61 Bn 6.41 Bn 19.10%
4 Boston Scientific 67.61 Bn 66.15 Bn 3.61 Bn 21.16%
5 Edwards Lifesciences 48.13 Bn 44.45 Bn 1.29 Bn 28.97%
6 Dexcom 28.26 Bn 27.14 Bn 750.30 Mn 21.42%
7 GE HealthCare Technologies 27.78 Bn 25.50 Bn 1.98 Bn 10.04%
8 Smith & Nephew 26.99 Bn 26.41 Bn - -
9 Koninklijke Philips 23.92 Bn 20.80 Bn 2.07 Bn 6.17%
10 Ceribell 677.56 Mn 536.38 Mn 23.12 Mn -78.30%

Historic Data

Download Data
DateValue
Mar 31, 2026 -78.30%
Dec 31, 2025 -58.89%
Sep 30, 2025 -64.84%
Jun 30, 2025 -70.53%
Mar 31, 2025 -69.33%
Dec 31, 2024 -69.52%
Sep 30, 2024 -57.79%
Jun 30, 2024 -55.08%
Mar 31, 2024 -58.70%
Dec 31, 2023 -63.83%
Sep 30, 2023 -61.70%